Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Bicara Therapeutics (BCAX) Q1 2025 Earnings
BCAX
27
Mar
Confirmed
Q4 2024
Q1 2025
-1.6
-1.18
-0.75
-0.33
Details
Expected EPS
-0.3292
Actual EPS
-0.39
Surprise EPS
-0.06
Surprise Percent
+18.47%
Description
Bicara Therapeutics (BCAX) has reported earnings of -0.39 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login